Close

Publications

FERNANDES, S; JIT, M; BOZZANI, F; GRIFFITHS, UK; SCOTT, JA G; BURCHETT, HE D;
2018
Vaccine, (2018).36 17 10.1016/j.vaccine.2018.02.049.
Kahn, R; Rid, A; SMITH, PG; Eyal, N; Lipsitch, M;
2018
PLoS medicine, (2018).15 8 10.1371/journal.pmed.1002632.
Hammitt, LL; Etyang, AO; Morpeth, SC; OJAL, J; Mutuku, A; Mturi, N; Moisi, JC; ADETIFA, IM; Karani, A; Akech, DO; OTIENDE, M; Bwanaali, T; Wafula, J; Mataza, C; Mumbo, E; Tabu, C; Knoll, MD; Bauni, E; Marsh, K; Williams, TN; Kamau, T; Sharif, SK; Levine, OS; SCOTT, JA G;
2018
Lancet, (2018).393 10186 10.1016/S0140-6736(18)33005-8.
Longini, IM; Røttingen, J-A; Kieny, MP; EDMUNDS, WJ; Henao-Restrepo, AM;
2018
Lancet, (2018).391 10125 10.1016/S0140-6736(18)30559-2.
NALWOGA, A; Miley, W; Labo, N; ELLIOTT, A; COSE, S; Whitby, D; NEWTON, R;
2018
The Pediatric infectious disease journal, (2018).37 8 10.1097/INF.0000000000001909.
JARVIS, CI; Altamirano, J; Sarnquist, C; EDMUNDS, WJ; Maldonado, Y;
2018
Clinical infectious diseases, (2018).67 suppl_ 10.1093/cid/ciy622.
Vekemans, J; Moorthy, V; Giersing, B; Friede, M; Hombach, J; Arora, N; Modjarrad, K; SMITH, PG; Karron, R; Graham, B; Kaslow, DC;
2018
VACCINE, (2018).37 50 10.1016/j.vaccine.2017.09.092.
Mathematical modelling of the epidemiological impact, cost-effectiveness and budget impact of novel tuberculosis vaccines on multidrug-resistant tuberculosis [Oral presentation].
WEERASURIYA, C; Harris, R; BOZZANI, F; MCQUAID, C; KNIGHT, G; SUMNER, T; Gomez, GB; WHITE, R;
2018
International Journal of Tuberculosis and Lung Disease, (2018).22 11